US FDA has granted clearance of DaylightRx for generalized anxiety disorder
-
learn more here.
Our Solutions
Comprehensive Solution
SleepioRx
DaylightRx
Sleepio
Daylight
Spark Direct
Who We Serve
Employers
Health Plans
Benefits Consultants
Our Results
Our Research
Patient Stories
Resources
Reports
Tools
Webinars
Blog
Who We Are
About Us
Careers
News
Contact Us
Get started
US
UK
Latest news
September 4, 2024
/
News
US FDA Grants Clearance for DaylightRx
US FDA Grants Clearance for SleepioRx
August 8, 2024
/
News
Study Finds Spark Direct Effective in Improving Mood Among Adults With Depression
May 23, 2024
/
News
Running the Next Leg
April 2, 2024
/
News
The mental health system of the future, delivered today
January 2, 2024
/
News
All News
Daily briefings for mental health?
The urgent need for scalable psychological treatment, and other takeaways from the New York Times
December 17, 2021
/
News
The new era of population health: Digital therapeutics for mental health
December 15, 2021
/
News
Scotland becomes first country in the world to make digital therapeutics for anxiety and insomnia available nationally
Through an expanded relationship, NHS Scotland will offer Big Health’s digital therapeutics for anxiety and insomnia to all adults, providing more than five million people access to cognitive behavioural therapy.
October 13, 2021
/
News
Study demonstrates combining digital therapeutics for insomnia and IAPT therapy improves sleep, anxiety, and depression more than therapy alone
Twelve-month evaluation shows the value of incorporating Big Health’s Sleepio, a clinically-based digital therapeutic for insomnia, into a psychological therapies stepped-care model.
September 1, 2021
/
News
Big Health and EHIR introduce Mental Health Maturity Index, measuring employer progress toward better mental health
Survey of large employers covering more than two million lives finds companies embracing mental health support but lack meaningful measures of success.
May 25, 2021
/
News
Big Health names mental health equity expert and clinical psychologist, Dr. Juliette McClendon, Director of Medical Affairs
Dr. McClendon will lead the medical affairs function with a focus on increasing the reach of Big Health’s mental health solutions.
May 3, 2021
/
News
Previous
Load More
Let's talk
For all media-related queries, please get in touch with us.
press@bighealth.com
Who we are
Learn about our mission, leadership, advisors, and investors.
About us